GPR15 and neoplasm: MC38 cells were injected subcutaneously in Gpr15-Het and -KO mice, and tumor development was monitored following concomitant intratumoral injection of GPR15L or vehicle (PBS) when tumors reached 4-5 mm in size (Day 4 post-transplant).